Medtric Biotech

company

About

Medtric Biotech develops eco-friendly antimicrobial technologies for the medical, industrial, and agricultural markets.

  • 1 - 10

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$100K
Industries
Health Care,Information Technology
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

Medtric aims to provide a measurable difference by delivering clinically robust and economically sensible wound care solutions. They formed the company with this simple vision in mind. Focus on Innovation: Their company's focus is on developing innovative products to advance patient care. The company's flagship technology was developed collaboratively at leading research and medical institutions. Their nanoscale-based therapy was specifically engineered to protect wounds against infection and advance the healing process. Strategy for Growth: As they look to the future, their strategy is to enter the expanding clinical and over the counter wound care markets. It will also leverage this platform to penetrate alternative applications including the treatment of acne and other topical infections. Their strategy ensures a strong foundation with expansive capabilities.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$279.57K
Medtric Biotech has raised a total of $279.57K in funding over 2 rounds. Their latest funding was raised on Mar 14, 2013 from a Pre-seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 14, 2013 Pre-seed $100K 1 Emerging Innovations Fund Detail
Dec 6, 2012 Grant $179.57K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Medtric Biotech is funded by 2 investors. Emerging Innovations Fund and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Emerging Innovations Fund Yes Pre-seed
National Science Foundation Yes Grant